CN103393998B - A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis - Google Patents

A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis Download PDF

Info

Publication number
CN103393998B
CN103393998B CN201310331000.5A CN201310331000A CN103393998B CN 103393998 B CN103393998 B CN 103393998B CN 201310331000 A CN201310331000 A CN 201310331000A CN 103393998 B CN103393998 B CN 103393998B
Authority
CN
China
Prior art keywords
parts
treatment
radix
liver cirrhosis
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310331000.5A
Other languages
Chinese (zh)
Other versions
CN103393998A (en
Inventor
孟钧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310331000.5A priority Critical patent/CN103393998B/en
Publication of CN103393998A publication Critical patent/CN103393998A/en
Application granted granted Critical
Publication of CN103393998B publication Critical patent/CN103393998B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis, it is characterized in that being made up of the raw material of following weight proportion: Rhizoma Sparganii 10-30 part, Pseudobulbus Cremastrae Seu Pleiones 5-15 part, Rhizoma Paridis 3-10 part, Caulis Spatholobi 5-20 part, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10-20 part, Cornu Bubali 10-20 part, Radix Rehmanniae Preparata 5-10 part, Poria 5-15 part, Hedyotidis Diffusae 5-15 part, Artemisia anethoicles Mattf 5-20 part, Fructus Gardeniae 3-10 part, Radix Paeoniae Alba 10-30 part, Radix Astragali 10-40 part, Radix Angelicae Sinensis 10-30 part, Fructus Lycii 5-15 part, Carapax Trionycis 5-15 part.The Chinese crude drug of said ratio of the present invention with the use of, there is evident in efficacy, that specimen is part-time feature, and less recurrence after curing.In addition, the present invention is that pure Chinese medicine is made, and therefore has toxic and side effects little, the advantages such as treatment cost is low.

Description

A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis
Technical field:
The present invention relates to Chinese medicine medicine technology field, more precisely a kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis.
Background technology:
Liver cirrhosis is a kind of common chronic hepatopathy, the pathogenesis mainly diffusivity hepatic injury that formed of or repeated action long-term by one or more causes of disease.This liver cirrhosis wherein caused because of hepatitis and alcoholic liver and fatty liver is the most common clinically.
The treatment of current doctor trained in Western medicine to obstinate type hepatopathys such as liver cirrhosis is nothing but use the medicine of nucleoside (acid) class to carry out long-term treatment.This therapeutic modality is not only treated and slowly, is easily recurred, and owing to taking medicine in a large number for a long time, persistence can be caused to injure to other internal organs such as kidney etc. of patient.
The traditional Chinese medical science thinks that the formation of liver cirrhosis is by damp and hot, evil poison infringement liver and gall, brings disaster to taste, causes dead blood glue to coagulate caused by the liver pulse.Mostly treatment is based on depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, nourishing blood to suppress the hyperactive liver, inducing diuresis to remove edema.But treatment cycle is long, DeGrain.
In view of this: use western medicine, hepatitis B and the hepatopathy such as liver cirrhosis transformed because of hepatitis B, have long, drug withdrawal medicine time easily repeatedly and toxic and side effects is large; Use treatment by Chinese herbs, DeGrain, and the shortcoming such as treatment cycle is very long.
Summary of the invention:
Object of the present invention is exactly to solve in prior art hepatopathys such as liver cirrhosis, therapeutic effect is poor, treatment cycle is long, cause the shortcomings such as certain infringement to other internal organs of patient, provides a kind of Traditional Chinese drug mixture of with low cost, evident in efficacy, treatment liver cirrhosis that toxic and side effects is little.
A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis provided by the invention is made up of the raw material of Chinese medicine of following weight proportion:
Rhizoma Sparganii 10-30 part, Pseudobulbus Cremastrae Seu Pleiones 5-15 part, Rhizoma Paridis 3-10 part, Caulis Spatholobi 5-20 part, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10-20 part, Cornu Bubali 10-20 part, Radix Rehmanniae Preparata 5-10 part, 5-15 parts, Poria, Hedyotidis Diffusae 5-15 part, Artemisia anethoicles Mattf 5-20 part, Fructus Gardeniae 3-10 part, Radix Paeoniae Alba 10-30 part, Radix Astragali 10-40 part, Radix Angelicae Sinensis 10-30 part, Fructus Lycii 5-15 part, Carapax Trionycis 5-15 part.
Record according to " Chinese medicine pharmacopeia ", the principal agent part in above-mentioned formula: Rhizoma Sparganii has removing blood stasis, promoting the circulation of QI to relieve pain effect; Pseudobulbus Cremastrae Seu Pleiones has heat-clearing and toxic substances removing, effect of dispersing swelling and dissipating binds; Rhizoma Paridis, Gymnospermium kiangnanense (P. L. Chiu) Loconte, Caulis Spatholobi, Cornu Bubali all have effect of removing pathogenic heat from blood and toxic substance from the body, reducing swelling and alleviating pain; Radix Rehmanniae Preparata has effect of clearing away heat and cooling blood YIN nourishing and the production of body fluid promoting; Particularly Agkistrodon house grass, Poria and Rhizoma Sparganii compatibility treat qi depression to blood stasis, and pyretic toxicity pent-up has unique curative effect: and Artemisia anethoicles Mattf and Fructus Gardeniae think that compatibility can play effect of eliminating damp-heat eliminating jaundice.
Accessory drugs part: the Radix Paeoniae Alba has effect of easing the affected liver of enriching blood, suppressing the hyperactive liver pain relieving; The Radix Astragali has effect of invigorating QI to consolidate the body surface resistance, diuresis toxin expelling, expelling pus and promoting granulation; Radix Angelicae Sinensis and Fructus Lycii have effect of blood-enriching qi-invigorating: Carapax Trionycis has nourishing YIN for suppressing the hyperactive YANG, and hard masses softening and resolving disappears effect of painful abdominal mass; Carapax Et Plastrum Testudinis has nourishing YIN for suppressing the hyperactive YANG, kidney tonifying bone strengthening, the effect of reinforcing the heart of nourishing blood; Fructus Crataegi (parched to brown) has effect of promoting digestion and invigorating the stomach, blood circulation promoting and blood stasis dispelling; Fructus Jujubae have protect the liver, spleen invigorating, the effect such as benefiting qi and nourishing blood.
The Chinese crude drug of said ratio of the present invention with the use of, there is evident in efficacy, that specimen is part-time feature, and less recurrence after curing.In addition, the present invention is that pure Chinese medicine is made, and therefore has toxic and side effects little, the advantages such as treatment cost is low.
Detailed description of the invention:
Embodiment one:
Rhizoma Sparganii 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Rhizoma Paridis 3 parts, Caulis Spatholobi 5 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10 parts, Cornu Bubali 10 parts, Radix Rehmanniae Preparata 10 parts, Artemisia anethoicles Mattf 15 parts, Fructus Gardeniae 5 parts, 5 parts, Poria, Hedyotidis Diffusae 5 parts, the Radix Paeoniae Alba 10 parts, the Radix Astragali 10 parts, Radix Angelicae Sinensis 10 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts.
This side is applicable to: the hepatic ascites that early metaphase liver cirrhosis and early metaphase liver cirrhosis cause.
To note during use: this side will be cautious use of for old and teenage patient, the patient that takes medicine will have a rest more, drink more water so that diuresis toxin expelling.
Instructions of taking: every day takes potion, every agent Chinese medicine decocting twice, sooner or later respectively once takes after meal half an hour, before boiling medicine first with warm water by herbal medicine immersion about 30 minutes, to be then placed on after stove fire is boiled, then slow fire boiling about 30 minutes of converting.Metalware should not be used to decoct, use marmite to decoct the most suitable.
Case: patient Li Weixin, man, 39 years old, have hepatitis B medical history for many years, when being hospitalized for treatment, health is weak, and stomach is scorching, xanthochromia, checks: early stage liver cirrhosis, splenomegaly through Mingguang City institute of traditional Chinese medicine.Through the treatment of three courses for the treatment of, liver power recovery is normal, after take medicine again three courses for the treatment of through color ultrasonic diagnosis: liver and gall spleen no abnormality seen.By further consultation inspection, without recurrence mark over 3 years.
Embodiment two:
Rhizoma Sparganii 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Rhizoma Paridis 3 parts, Caulis Spatholobi 5 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10 parts, Cornu Bubali 10 parts, Radix Rehmanniae Preparata 10 parts, Artemisia anethoicles Mattf 15 parts, Fructus Gardeniae 5 parts, 5 parts, Poria, Hedyotidis Diffusae 5 parts, the Radix Paeoniae Alba 10 parts, the Radix Astragali 10 parts, Radix Angelicae Sinensis 10 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts, Fructus Crataegi (parched to brown) 5 parts, 10 parts, Fructus Jujubae.
Case: patient Zhang Xianhua, man, 54 years old, patient had hepatitis B medical history more than 10 year, formed ascites more than 3 years, found on inspection, abnormal liver function, liver cirrhosis, splenomegaly abdominal part opaque dark area of fluid 8cm when being hospitalized for treatment.Listless all day, anorexia.Treatment patient liver power recovery through five courses for the treatment of is good, and transaminase is normal, and ascites disappears, and liver's blood flow enriches, and patient mental is in good condition.By further consultation inspection, without recurrence sign over 3 years.
Embodiment three:
Rhizoma Sparganii 20 parts, Pseudobulbus Cremastrae Seu Pleiones 10 parts, Rhizoma Paridis 8 parts, Caulis Spatholobi 10 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10 parts, Cornu Bubali 10 parts, Radix Rehmanniae Preparata 10 parts, Artemisia anethoicles Mattf 20 parts, Fructus Gardeniae 10 parts, 10 parts, Poria, Hedyotidis Diffusae 10 parts, the Radix Paeoniae Alba 10 parts, the Radix Astragali 10 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts, Carapax Et Plastrum Testudinis 5 parts, 10 parts, Fructus Jujubae.
Case: patient Sun Cailian, female 52 years old.Suffering from liver cirrhosis nearly ten years, intermittent use over 10 years, bad during symptom fashion, there is hypomnesis in aggravation before a week, and has obnubilation, finds through color ultrasound: liver cirrhosis, hepatic ascites, air spots, portal vein 1.4cm, the thick 4.5cm of spleen.Treatment patient liver power recovery through five courses for the treatment of is normal, and ascites disappears, and portal vein attenuates, and spleen recovers normal.
Embodiment four:
Rhizoma Sparganii 20 parts, Pseudobulbus Cremastrae Seu Pleiones 8 parts, Rhizoma Paridis 7 parts, Caulis Spatholobi 10 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10 parts, Cornu Bubali 15 parts, Radix Rehmanniae Preparata 5 parts, Artemisia anethoicles Mattf 20 parts, 10 parts, Fructus Gardeniae 10 parts of Poria, Hedyotidis Diffusae 10 parts, the Radix Paeoniae Alba 15 parts, the Radix Astragali 25 parts, Radix Angelicae Sinensis 15 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts, Carapax Et Plastrum Testudinis 5 parts, Fructus Crataegi (parched to brown) 7 parts, 10 parts, Fructus Jujubae.
Case: patient horse is joyful, female, 45 years old, hepatitis B medical history is had but conscientiously not treat for many years, when being admitted to hospital, abdominal distention poor appetite, xanthochromia, myasthenia of limbs, and with nausea and vomiting, through Wuhe County examination in hospital, abnormal liver function, with liver cirrhosis, ascites, patient takes traditional Chinese medicine three courses for the treatment of, and symptom disappears substantially, and taken two the course for the treatment of Chinese medicine, the symptom of patient disappears completely, and liver power checking is normal.By further consultation inspection, without recurrence sign over 3 years.
Embodiment five:
Rhizoma Sparganii 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Rhizoma Paridis 5 parts, Caulis Spatholobi 5 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 15 parts, Cornu Bubali 15 parts, Radix Rehmanniae Preparata 0 part, Artemisia anethoicles Mattf 10 parts, 5 parts, Fructus Gardeniae 3 parts of Poria, Hedyotidis Diffusae 5 parts, the Radix Paeoniae Alba 10 parts, the Radix Astragali 20 parts, Radix Angelicae Sinensis 15 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts, 15 parts, Fructus Jujubae.
Case: patient Dong Ruyi, man, 32 years old, patient found liver cirrhosis before 3 years, showed abnormal liver function on inspection: transaminase 120u/L, and hepatic fibrosis index increases, and color ultrasound shows: liver cirrhosis, splenomegaly.After having taken two courses for the treatment of of the present invention, symptom takes a turn for the better, and after continuing again to have taken two course for the treatment of Traditional Chinese drug mixtures, liver function recovery is normal, and hepatic fibrosis index is normal, and spleen bounces back, and stable disease, reaches clinical cure substantially.By further consultation inspection, without recurrence sign over 2 years.

Claims (1)

1. treat a Chinese medicine for liver cirrhosis, it is characterized in that being made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Sparganii 20 parts, Pseudobulbus Cremastrae Seu Pleiones 8 parts, Rhizoma Paridis 7 parts, Caulis Spatholobi 10 parts, Gymnospermium kiangnanense (P. L. Chiu) Loconte 10 parts, Cornu Bubali 15 parts, Radix Rehmanniae Preparata 5 parts, Artemisia anethoicles Mattf 20 parts, Fructus Gardeniae 10 parts, 10 parts, Poria, Hedyotidis Diffusae 10 parts, the Radix Paeoniae Alba 15 parts, the Radix Astragali 25 parts, Radix Angelicae Sinensis 15 parts, Fructus Lycii 10 parts, Carapax Trionycis 5 parts, Carapax Et Plastrum Testudinis 5 parts, Fructus Crataegi (parched to brown) 7 parts, 10 parts, Fructus Jujubae.
CN201310331000.5A 2013-08-01 2013-08-01 A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis Expired - Fee Related CN103393998B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310331000.5A CN103393998B (en) 2013-08-01 2013-08-01 A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310331000.5A CN103393998B (en) 2013-08-01 2013-08-01 A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis

Publications (2)

Publication Number Publication Date
CN103393998A CN103393998A (en) 2013-11-20
CN103393998B true CN103393998B (en) 2015-07-29

Family

ID=49557851

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310331000.5A Expired - Fee Related CN103393998B (en) 2013-08-01 2013-08-01 A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis

Country Status (1)

Country Link
CN (1) CN103393998B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816815A (en) * 2016-05-13 2016-08-03 任开俊 Traditional Chinese medicine for treating liver cirrhosis and liver ascites and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1850256B (en) * 2006-02-11 2011-06-22 王福斗 Pill for treating hepatitis B
CN101716311B (en) * 2009-10-31 2011-05-11 郭照明 Traditional Chinese medical pill for treating hepatitis B

Also Published As

Publication number Publication date
CN103393998A (en) 2013-11-20

Similar Documents

Publication Publication Date Title
CN1803187A (en) Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny
CN101396527A (en) Traditional Chinese medicine formulation for treating migraine
CN102973862A (en) Chinese medicine preparation for treating skin itch
CN104288496A (en) Traditional Chinese medicine composition for treating constipation
CN104069466A (en) Traditional Chinese medicament for treating uremia
CN103623157A (en) Medicine for treating facial paralysis
CN103393998B (en) A kind of Traditional Chinese drug mixture for the treatment of liver cirrhosis
CN103860675A (en) Composition for treating rheumatoid arthritis
CN104606573A (en) Traditional Chinese medicine used for treating arthritis
CN102579706B (en) Traditional Chinese medicine for treating urinary stone
CN101757321A (en) Decoction medicine for treating impetigo
CN105288367A (en) Internal traditional Chinese medicine composition for treating eczema
CN104523965A (en) Nephritis treating traditional Chinese medicine composition
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN103272183B (en) Traditional Chinese medicine for treating hepatitis B induced cirrhosis
CN102784212A (en) Chinese medicine composition for treating arthralgia-synadrome
CN100998720B (en) Oral traditional Chinese medicine for treating amenorrhea of uterus stasis
CN103566266B (en) Traditional Chinese medicine mixture for treating waist and leg rheumatalgia
CN102772580A (en) Traditional Chinese medicine decoction for treating migraine and preparation method thereof
CN100998707B (en) Medical herbs of decoction for treating sciatica and its preparing method
CN101176768A (en) Epityphlon health
CN101002864B (en) Decoction for treating old lumbar soft tissue injury, and its preparing method
CN101890069A (en) Medicament for preventing and treating gout and preparation process thereof
CN104888017A (en) Medicine for treating hepatitis B
CN104491480A (en) Rheumatalgia-relieving and collaterals-activating wine and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150729

Termination date: 20160801